BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6479225)

  • 1. Guanyl nucleotides decrease antagonist binding at high affinity dopamine receptors.
    Andorn AC; Kohagen KR
    Eur J Pharmacol; 1984 Aug; 103(1-2):127-31. PubMed ID: 6479225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
    Richfield EK; Young AB; Penney JB
    Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopamine on activation of rat striatal adenylate cyclase by free Mg2+ and guanyl nucleotides.
    McSwigan JD; Nicol SE; Gottesman II; Tuason VB; Frey WH
    J Neurochem; 1980 Mar; 34(3):594-601. PubMed ID: 7354334
    [No Abstract]   [Full Text] [Related]  

  • 10. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of guanosine nucleotides of [3H]sulpiride binding to rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    Eur J Pharmacol; 1981 Jan; 69(1):117-8. PubMed ID: 7202509
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of [3H]spiroperidol binding by in vitro addition of ethanol.
    Hruska RE; Silbergeld EK
    J Neurochem; 1980 Sep; 35(3):750-2. PubMed ID: 7452286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Munemura M; Agui T; Sibley DR
    Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of guanine nucleotides on striatal dopamine receptors.
    Zahniser NR; Molinoff PB
    Nature; 1978 Oct; 275(5679):453-5. PubMed ID: 692725
    [No Abstract]   [Full Text] [Related]  

  • 18. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Eur J Pharmacol; 1980 May; 63(2-3):217-22. PubMed ID: 6155277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.